Subscribers

Bayer considering sale of its diabetes device business

London

BAYER AG is exploring the sale of its diabetes device business as the German company focuses on faster-growing medicines, according to people with knowledge of the matter.

Leverkusen, Germany-based Bayer is working with Credit Suisse Group AG on the potential sale, three of the people said, asking...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes